Pharmacists Management of Diabetes

Diabetes Mellitus Clinical Trial

Official title:

Pharmacist Management of Diabetes Mellitus: A Randomized Controlled Trial.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00869076
• Other study ID #: PharmacistDiabetesJameson
• Status: Completed
• Phase: Phase 4
• First received: March 23, 2009
• Last updated: March 24, 2009
• Start date: May 2006
• Est. completion date: December 2007

Study information

• Verified date: March 2009
• Source: Advantage Health Physician Network
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The hypothesis is that patients with poorly controlled diabetes would have greater improvement in their blood sugar control when managed by a clinical pharmacist than when managed with usual medical care. Patients with poor control are randomized to pharmacist management or to usual medical care for one year.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 102
• Est. completion date: December 2007
• Est. primary completion date: December 2007
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age 18 years or older

• A1c greater than or equal to 9.0

Exclusion Criteria:

• Not expected to live for the duration of the study

• Managed by an endocrinologist

• Unwillingness to participate and attend pharmacist visits

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Diabetes Mellitus

Intervention

Other:
• Pharmacist Management
Pharmacist Managed the patient's diabetes in collaboration with their primary care physician
• Usual care
Patient was managed by their primary care physician as usual

Locations

Country	Name	City	State
United States	Advantage Health Physican Network	Grand Rapids	Michigan

Sponsors (5)

Lead Sponsor	Collaborator
Advantage Health Physician Network	Doran Foundation, Michigan Pharmacist Foundation, Priority Health, Western Michigan Society of Health System Pharmacists

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hgb A1c change		1 year	No
Secondary	HgbA1c change based on ethnicity		one year	No
Secondary	percent of patients with a 1 point or greater decrease in A1c		one year	No
Secondary	Percent of patients with a 1 point decrease in A1c by ethnicity		one year	No